MDSpire - Takeaway
Clinical Guidelines

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

These results come from the pilot phase of the phase III ADARNAT randomized international clinical trial, which is investigating whether axillary radiotherapy has a lower risk of lymphedema than axill...

Share

  • 1

    Axillary radiotherapy may reduce lymphedema risk in breast cancer.

  • 2

    ART is being compared to ALND in the ADARNAT trial.

  • 3

    Follow-up showed no axillary cancer recurrences in the ART group.

  • 4

    Skin damage from ART was mostly transient.

  • 5

    Trial involved 272 breast cancer patients treated with neoadjuvant therapy.

  • 6

    Results could lead to less invasive treatment strategies.

  • 7

    Future research is necessary to confirm ART's long-term effectiveness.

Original Source(s)

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

  • by The ASCO Post Staff

  • March 30, 2026

Related Content

New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes

Breast Cancer Recurrence Remains Low—Even After 10 Years—With Radiotherapy Tailored to Patient’s Individual Risk

“The results of our study show that tailoring the extent of radiotherapy according to how well the chemotherapy has worked to treat cancer in the lymph nodes leads to very low and reassuring recurrenc...

Therapeutic Advances in Metastatic Melanoma: TILs, ImmTACs, and Targeted Therapies